Search for: "Doe v. Allergan, Inc. et al" Results 1 - 20 of 21
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2013, 4:33 pm
On May 1, the US Court of Appeals for the Federal Circuit issued an interesting, yet controversial, ruling in Allergan Inc. v Sandoz Inc. et Al., examining obviousness in the context of a combination ophthalmic drug treatment. [read post]
23 Jul 2018, 12:05 pm by Dennis Crouch
Damages – Enhanced Damages: Bombardier Recreational Products Inc., et al. v. [read post]
29 May 2011, 12:01 pm
Allergan et al v. [read post]
7 Sep 2011, 4:22 am by Marie Louise
  Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)… [read post]